Description
ELIQUIS 5MGS (Apixaban) is a crucial prescription anticoagulant (blood thinner) widely used to prevent and treat various life-threatening blood clot conditions. This 5mg dosage is commonly prescribed for preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF), where it significantly reduces the risk of dangerous clots forming in the heart. It is also a key component in the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), helping to dissolve existing clots and prevent new ones from forming.
Apixaban works by specifically targeting and inhibiting Factor Xa, an essential protein in the blood clotting cascade, thereby reducing the blood’s clotting ability. Due to its powerful action and the inherent risk of bleeding associated with anticoagulants, ELIQUIS 5MGS must be taken precisely as directed by a healthcare professional. Regular medical follow-up is essential to ensure safe and effective therapy.
